ICH Q7 Audit Checklist
Objective Evidence
- Quality management policy signed by senior management
- Organisational chart showing quality function reporting lines
- Quality system manual or equivalent high-level document
- Management review meeting minutes with attendance records
- Resource allocation records for quality activities
- Quality objectives and measurable targets
- Documented quality system procedures index
- Budget approvals for quality infrastructure and staffing
- Training records showing management quality awareness
Common Nonconformities
- No documented quality policy or quality system manual
- Senior management absent from quality review meetings
- Quality unit understaffed relative to production volume
- Quality system documents not reviewed or updated for years
- No measurable quality objectives defined
- Quality function reports to production management (lack of independence)
Auditor Tips
This is the foundational quality management principle for API manufacturing. Auditors should verify that senior management visibly participates in quality governance — not merely delegates it. Look for management attendance at quality review meetings, signed quality policies, and resource allocation decisions that demonstrate genuine commitment. The quality system must be comprehensive, covering organisational structure, written procedures, defined processes, adequate resources, and all activities that affect API quality and purity. A common FDA 483 observation is quality systems that exist on paper but lack evidence of active management participation or resource commitment.
Objective Evidence
- Organisational chart showing QU independence from production
- Quality unit charter or terms of reference
- Job descriptions for QA and QC roles with reporting lines
- Evidence of batch rejections or holds initiated by QU
- Documented authority matrix for quality decisions
- Meeting minutes showing QU exercising independent judgement
- Separation of QA/QC duties documented (or justification for combined role)
- Escalation procedure when QU and production disagree
Common Nonconformities
- Quality unit reports directly to production or plant manager
- No documented QU charter or authority statement
- No evidence QU has ever rejected or held a batch
- QU head also holds a production management role
- Production management can override QU decisions without escalation
- QU staff performance evaluated by production metrics
Auditor Tips
Independence of the quality unit from production is a critical GMP principle. Auditors should trace the reporting lines to confirm the quality unit does not report to the head of production or manufacturing. In small organisations a single individual may fulfil QA and QC roles, but that person must still have independent authority to reject batches without production override. Verify that quality decisions (batch release, deviation closure, CAPA approval) cannot be overruled by production management. FDA warning letters frequently cite situations where QU independence is compromised by organisational structure or informal pressure.
Objective Evidence
- Authorised signatory list for batch disposition
- Delegation of authority matrix for material release/rejection
- Qualification records for authorised personnel
- Batch records showing named individuals approving release
- Rejection reports with authorised signatures
- Raw material acceptance records with authorised signatures
- Acceptance criteria referenced in disposition decisions
- Periodic review of authorised signatory list
Common Nonconformities
- No formal authorised signatory list maintained
- Batch records signed by unqualified or undesignated personnel
- Rejection decisions not documented or not traceable
- Acceptance criteria not referenced in disposition records
- Outdated signatory lists with departed employees still listed
- No periodic review of authorised signatories
Auditor Tips
Auditors should request the list of authorised signatories for batch release, material acceptance, and rejection decisions. Verify that each person on the list has documented qualifications and formal delegation of authority. Cross- check actual batch records and rejection reports to confirm only authorised persons signed off. This clause also covers incoming raw materials — someone must be formally authorised to accept or reject them. Look for traceability: every disposition decision should link to a named individual, the date of decision, and the quality data that supported it. Unsigned or undated disposition records are a significant finding.
Objective Evidence
- Deviation SOP with defined timelines for initiation and closure
- Deviation log showing open/closed status and age metrics
- Batch records with contemporaneous entries (dates and times match activities)
- Investigation reports completed within SOP-defined timelines
- CAPA tracking system with due dates and completion rates
- Quality metrics dashboard showing deviation closure rates
- Logbook entries with real-time timestamps
- Escalation procedure for overdue quality activities
Common Nonconformities
- Large backlog of open deviations (more than 30 days old)
- Investigation reports completed months after the event
- Evidence of predated or retroactively completed records
- No defined timelines for deviation investigation and closure
- Quality hold decisions delayed, allowing potentially affected product to ship
- CAPA actions overdue without management escalation
Auditor Tips
This clause addresses two interrelated concepts: contemporaneous recording and timeliness. Auditors should verify that quality records are created at the time of the activity (not retrospectively filled in), and that deviations, investigations, and quality decisions are completed within defined timeframes. Look for SOP-defined timelines for deviation initiation, investigation completion, and CAPA implementation. A backlog of open deviations or investigations pending for months is a red flag. Also check for evidence of predated or post-dated entries in batch records or logbooks. Timeliness protects data integrity — delayed recording increases the risk of inaccurate information.
Objective Evidence
- Batch release procedure requiring QU signature
- Intermediate disposition records approved by QU
- Master batch record approval workflow showing QU sign-off
- Specification approval records with QU signatures
- Sampling procedure approvals by QU
- Test method approval and change records signed by QU
- Authority matrix showing QU as final authority for release/rejection
- Evidence that QU has exercised rejection authority
- SOP defining QU role in document review and approval
Common Nonconformities
- APIs released without QU approval signature
- Production staff performing batch disposition without QU oversight
- Master batch records issued without QU review
- Specifications changed without QU approval
- No evidence of QU rejecting any batch in extended period
- QU authority delegated to non-quality personnel
Auditor Tips
This clause establishes the quality unit as the final authority for all batch disposition decisions. Auditors should verify that no API batch can be released without explicit QU approval, and that QU also controls intermediate disposition. Beyond batch release, the QU must approve master batch records, specifications, sampling plans, and test methods before they are used. Check that this authority is not informally delegated — for example, a production supervisor should not be able to release APIs even temporarily. Also verify QU reviews and approves any changes to specifications or test methods. This is one of the most frequently cited areas in FDA warning letters for API manufacturers.
Objective Evidence
- SOPs for material receipt, identification, and quarantine
- SOPs for storage, handling, and sampling of materials
- SOPs for testing and release of in-process materials and APIs
- Deviation management SOP with root cause analysis methodology
- CAPA procedure with effectiveness verification requirements
- Process controls or interlocks designed to prevent deviations
- Deviation trending reports identifying recurring issues
- Preventive action implementation records with effectiveness checks
- Material flow diagram showing control points
Common Nonconformities
- Missing SOPs for one or more material handling steps
- No formal deviation management procedure
- Deviations investigated but no preventive actions implemented
- Recurring deviations with same root cause indicating ineffective CAPAs
- No systematic deviation trending or analysis
- Quarantine controls not enforced (materials used before release)
Auditor Tips
Auditors should verify a complete set of written procedures covering the full material lifecycle from receipt through final API release. Check that procedures exist for each step: receiving and identification, quarantine controls, storage conditions, handling precautions, sampling techniques, analytical testing, and formal disposition. Beyond having procedures, the clause requires systems that actively prevent deviations (process controls, interlocks, verification steps) and that deviations which do occur are promptly detected, properly investigated, and corrected with preventive measures. Verify that CAPA actions from deviation investigations are implemented and verified for effectiveness. The absence of a comprehensive deviation prevention programme is a common GMP shortcoming.
Objective Evidence
- Quarantine procedure with physical or system-based controls
- Warehouse management system showing material status tracking
- Labels or status indicators for quarantine vs. released materials
- Quality unit release records for raw materials and intermediates
- Formal approval documentation for any quarantine-release system
- Risk assessment for use of materials pending evaluation
- Physical segregation evidence (photos, layout diagrams)
- Incident reports for any inadvertent use of quarantined material
Common Nonconformities
- No physical or system-based quarantine controls in place
- Materials used in production before QU release without formal system
- Quarantine release system used without documented QU approval
- Inadequate labelling — quarantine status not clearly indicated
- Warehouse layout does not support physical segregation
- No records of quarantine holds or releases
Auditor Tips
This clause establishes the principle that quality evaluation must precede material use. Auditors should verify that physical or system-based quarantine controls prevent materials from entering production before QU release. If a quarantine release system (using materials before full evaluation is complete) is used, it must be formally approved with documented controls and risk assessment. Check warehouse management systems or physical segregation practices. Verify that labels or status indicators clearly distinguish quarantined from released materials. The most common finding is inadequate physical segregation allowing unreleased materials to be inadvertently used in production.
Objective Evidence
- Escalation and notification SOP with defined timelines
- Escalation matrix identifying notification recipients by scenario
- Records of management notifications for past inspections or events
- Recall notification procedure with regulatory authority contacts
- Internal communication records during regulatory inspections
- Mock recall or emergency drill records testing notification paths
- Complaint escalation records showing management involvement
- Contact information list for emergency notifications kept current
Common Nonconformities
- No formal notification or escalation procedure exists
- Notification procedure exists but has never been used or tested
- Regulatory inspections occurred without timely management notification
- Escalation timelines not defined or unrealistically long
- Senior management unaware of significant quality events
- Contact lists outdated with departed personnel
Auditor Tips
Auditors should verify that formal escalation and notification procedures exist and have been tested or used. Check for documented escalation paths with named roles (not just titles) and defined timelines — for example, notification of a regulatory inspection within 24 hours, or immediate notification for product safety issues. The procedure should cover multiple scenarios: announced and unannounced inspections, critical GMP findings from internal audits, field complaints indicating product defects, and recalls. Verify that the procedure reaches senior management who can authorise resource deployment for responses. A common gap is having a notification procedure that has never been tested via simulation or drill.
Objective Evidence
- Regulatory notification SOP with triggering criteria
- Regulatory authority contact matrix by jurisdiction
- Records of past regulatory notifications with timelines
- Designated responsible person(s) for regulatory communications
- Mapping of reporting obligations by market/jurisdiction
- Templates for regulatory notification submissions
- Training records for personnel responsible for notifications
- Log of all regulatory communications (inbound and outbound)
Common Nonconformities
- No procedure for regulatory notification exists
- Reportable events occurred without regulatory notification
- Notification procedure covers only one jurisdiction despite global distribution
- No designated responsible person for regulatory communications
- Notification timelines not aligned with regulatory requirements
- No records of any regulatory notifications ever made
Auditor Tips
Auditors should verify that the organisation has clear procedures for regulatory notifications — not just internal escalation but external reporting to health authorities. Check that the procedure defines triggering criteria (what constitutes a reportable event), reporting timelines per jurisdiction, responsible persons, and documentation requirements. For API manufacturers supplying globally, verify that procedures account for multiple regulatory authorities (FDA, EMA, PMDA, etc.) and different reporting timelines. Cross-reference with actual events to confirm notifications were made. A common gap is having domestic notification procedures but not covering international markets where the API is distributed.
Objective Evidence
- QU involvement matrix across all manufacturing stages
- QU participation in change control review records
- QU membership in technology transfer teams
- QU sign-off on validation protocols and reports
- QU attendance at process design and review meetings
- QU review of supplier qualification records
- Document approval workflows showing QU as required reviewer
- QU participation in out-of-specification investigations
- Periodic review records of QU scope and involvement
Common Nonconformities
- QU involvement limited to final batch testing and release
- Change controls approved without QU review
- Technology transfers completed without QU participation
- Validation protocols executed without QU approval
- QU not involved in supplier qualification decisions
- No documentation of QU scope of involvement
Auditor Tips
Auditors should verify the breadth of QU involvement across all quality-related activities — not just batch release and testing. Check that the QU participates in process design, validation protocols, change control reviews, and technology transfers. Look at meeting attendance records, document approval workflows, and project team rosters. The QU should also be involved in supplier qualification, stability programmes, and out-of-specification investigations. A common gap is QU involvement limited to end-stage testing and release, without participation in upstream process decisions that fundamentally affect API quality. The clause uses "all quality-related matters" — this is broad and intentional.
Objective Evidence
- List of document types requiring QU review and approval
- Batch production records with QU review signatures and dates
- Laboratory control records with QU review evidence
- Deviation reports showing QU review and approval
- Change control records with QU approval signatures
- Validation protocols and reports with QU approval
- Specification documents with QU approval history
- Document review SOP with defined timelines
- Metrics on QU document review turnaround times
Common Nonconformities
- Documents issued without QU review or approval
- QU review signatures backdated or retroactive
- No evidence of substantive QU review (no comments or corrections ever)
- Large backlog of documents awaiting QU review
- No defined list of documents requiring QU review
- QU review turnaround times not tracked or consistently exceeded
Auditor Tips
Auditors should request a comprehensive list of documents subject to QU review and approval and verify it covers all categories listed in this clause. Spot-check actual documents to confirm QU review signatures are present and timely. Check that the review is substantive — not merely a rubber stamp — by looking for evidence of QU comments, corrections, or rejections during reviews. The timeframe for review should be defined in procedures and tracked. A backlog of documents awaiting QU review suggests inadequate QU resources. Also verify that QU reviews are completed before the document is used (not retroactively approved).
Objective Evidence
- QU duties matrix mapping all 15 duties to SOPs and responsible persons
- API batch release records signed by QU
- Intermediate disposition records for external use
- Raw material, packaging, and labelling material release system records
- Batch record review checklists for critical process steps
- Deviation investigation records approved by QU
- Master production instruction approval records
- Internal audit programme and audit reports
- Contract manufacturer approval records
- Change control records with QU approval
- Validation protocol and report approval records
- Quality complaint investigation records
- Equipment calibration and maintenance oversight records
- Material testing oversight and result review records
- Stability programme and data review records
- Product quality review reports
Common Nonconformities
- One or more of the 15 duties not assigned to QU in writing
- QU duties delegated to non-quality personnel without formal authorisation
- No evidence of QU performing specific duties (e.g., no internal audits conducted)
- API released without QU batch record review
- Contract manufacturers approved without QU involvement
- No product quality review programme in place
- Stability programme not overseen by QU
Auditor Tips
This is the most detailed clause in Section 2 and represents the core duties of the quality unit. Auditors should verify that each of the 15 listed duties is explicitly assigned to the QU, documented in writing, and actively performed with supporting evidence. Create a matrix mapping each duty to the responsible QU personnel, the governing SOP, and evidence of execution. Any duty that lacks a governing procedure or evidence of execution within the audit period is a potential finding. Note the clause states these duties should not be delegated outside the QU — verify there are no informal delegations. This clause is the single most important reference for QU compliance in API manufacturing under ICH Q7.
Objective Evidence
- Production responsibilities document or SOP
- Master production instructions signed and distributed
- Batch records showing production review and sign-off
- Production deviation reports submitted to QU
- Facility cleaning and disinfection logs
- Calibration records maintained by production
- Equipment maintenance logs and schedules
- Production management review of validation protocols
- Change evaluation records with production input
- Equipment qualification records with production sign-off
- Job descriptions defining production quality responsibilities
Common Nonconformities
- Production responsibilities not documented in writing
- Batch records not reviewed or signed by production management
- Production deviations not reported or reported late
- No cleaning or maintenance logs for production facilities
- Calibration records missing or incomplete
- Production not involved in change evaluation for process changes
- New equipment used without qualification
Auditor Tips
Auditors should verify that each of the 10 listed production responsibilities is formally assigned, documented in SOPs, and actively performed with supporting evidence. Create a matrix similar to the QU duties in clause 2.22. Check that production management's responsibilities complement but do not overlap with QU responsibilities — the two should be clearly delineated. Look for evidence of production personnel performing each duty: production instructions prepared and distributed, batch records reviewed and signed, deviations reported to QU, facility cleaning logs, calibration records, maintenance logs, validation involvement, change evaluation participation, and equipment qualification records. Production and quality should have clear handoff points defined.
Objective Evidence
- Internal audit schedule covering all GMP areas (risk-based frequency)
- Internal audit SOP defining methodology, classification, and reporting
- Auditor qualification records demonstrating independence and competence
- Completed audit reports with observations classified by severity
- Corrective action plans with responsible persons and due dates
- CAPA tracking system showing completion status of audit findings
- Management review presentation of internal audit results
- Follow-up audit records verifying effectiveness of corrective actions
- Audit programme annual review and risk re-assessment records
Common Nonconformities
- No internal audit programme or schedule in place
- Audits not covering all GMP areas per ICH Q7
- Auditors not independent from the area being audited
- Audit reports with zero findings over multiple years
- Corrective actions from audits not completed or overdue
- No management review of internal audit results
- Audit schedule not risk-based — all areas audited at same frequency
Auditor Tips
Auditors should review the internal audit programme schedule to verify it covers all GMP areas per ICH Q7. Check that audits are performed by personnel who did not work in the area being audited (independence). Review audit reports for completeness — they should identify observations, classify them by severity, and include agreed corrective actions with responsible persons and due dates. Verify that corrective actions are tracked to completion and their effectiveness verified. The audit schedule should be risk-based — higher-risk areas (e.g., aseptic processing, water systems, data integrity) should be audited more frequently. A common finding is internal audits that are superficial or never identify any observations, suggesting lack of rigour.
Objective Evidence
- CAPA tracking system or log for internal audit findings
- Root cause analysis records for audit observations
- Corrective action implementation evidence
- Effectiveness verification records for completed CAPAs
- Overdue CAPA escalation records to management
- Management meeting minutes addressing audit CAPA status
- Trend report showing audit finding recurrence rates
- Metrics on CAPA on-time closure rates
Common Nonconformities
- No CAPA tracking system for audit findings
- Corrective actions overdue without management escalation
- No root cause analysis performed for audit findings
- Same findings recurring in consecutive audit cycles
- No effectiveness verification for completed corrective actions
- Management not informed of overdue audit CAPAs
Auditor Tips
Auditors should review the CAPA tracking system for internal audit findings. Check that each audit observation has an assigned corrective action with a responsible person, target completion date, and root cause analysis. Verify that completed actions include effectiveness verification — evidence that the root cause was actually eliminated. Calculate the on-time closure rate: if a significant proportion of CAPAs are overdue, this indicates a systemic issue. Also check that management is informed of overdue actions and that resources are allocated for completion. Common gaps include corrective actions that address symptoms rather than root causes, leading to recurring findings in subsequent audit cycles.
Objective Evidence
- Product quality review reports for each API (annual)
- Statistical trending of in-process controls and API test results
- Summary and analysis of failed batches
- Review of critical deviations with root cause patterns
- Summary of process and analytical method changes
- Stability monitoring programme results and trending
- Complaint and recall summary with trend analysis
- CAPA effectiveness assessment
- Conclusions and recommendations for corrective action or revalidation
- Management sign-off on PQR conclusions and actions
Common Nonconformities
- No product quality review programme in place
- PQRs overdue by more than one year
- PQR compiles data but contains no analysis or conclusions
- One or more of the seven required review elements missing
- No statistical trending of critical results
- PQR recommends corrective actions but no follow-through documented
- Process consistency issues identified but not acted upon
Auditor Tips
The product quality review (PQR), sometimes called annual product review (APR), is a critical retrospective analysis of process consistency. Auditors should verify that PQRs are conducted at least annually for each API and include all seven specified review elements. Check that the review includes statistical trending (not just listing) of in-process controls and test results. Verify that failed batches, deviations, changes, stability data, complaints, and CAPA effectiveness are all evaluated. The review should conclude with an assessment of whether the process remains in a validated state of control. Recommendations for corrective action or revalidation should be documented and tracked. Common gaps include PQRs that compile data without analysis, or reviews that are overdue by months or years.
Objective Evidence
- PQR conclusions section with corrective action assessment
- Documented rationale for corrective action decisions
- CAPA records arising from PQR findings
- Revalidation assessments triggered by PQR trends
- Specification or method change proposals resulting from PQR
- Process control revisions based on PQR analysis
- Trending data showing early identification of process drift
- PQR action items tracked to completion with timelines
- Continuous improvement programme inputs from PQR
Common Nonconformities
- PQR completed but no assessment of corrective action need
- Negative trends identified in PQR but no action taken
- Revalidation not considered despite process changes or drift
- PQR corrective actions not tracked or completed
- PQR treated as standalone exercise with no link to improvement programme
- Same negative trends reported in consecutive PQRs without resolution
Auditor Tips
This clause extends clause 2.50 by requiring that PQR findings lead to actionable outcomes. Auditors should verify that PQR conclusions include a documented assessment of whether corrective action or revalidation is needed, with supporting rationale. Where corrective actions are identified, verify they are tracked and completed in a timely manner. Check that the PQR specifically evaluates whether specifications, test methods, process controls, or manufacturing procedures need updating based on the trends observed. The PQR should identify process drift before it results in out-of-specification results. Also verify the PQR feeds into the broader continuous improvement programme — it should not be an isolated annual exercise but a driver of quality system improvements.
Objective Evidence
- Organization charts showing staffing levels
- Job descriptions for all GMP roles
- Qualification matrices (education + training + experience)
- Personnel files with qualifications
- Staffing vs workload assessment
- Training records demonstrating competency
- Succession planning documentation
- Resource adequacy reviews
Common Nonconformities
- Understaffing leading to quality compromises
- Job descriptions missing or outdated
- Unqualified personnel performing GMP tasks
- No succession planning for key roles
- Qualification gaps not addressed
- Overtime-driven fatigue impairing batch record accuracy
Auditor Tips
Staffing must be sufficient for the workload with qualified personnel. Qualification criteria include: education (typically degrees relevant to the role), training (GMP and job-specific), experience (years in similar roles). Written responsibilities (job descriptions, responsibility matrices) prevent ambiguity about who does what. Under-staffing leads to shortcuts and quality failures.
Objective Evidence
- GMP training curriculum
- Initial training program for new hires
- Job-specific training records
- Training matrices by role
- Training effectiveness assessments (quizzes, observations)
- Periodic refresher training records
- Training conducted by qualified trainers
- New employee verification before independent work
Common Nonconformities
- Training limited to attendance records without effectiveness assessment
- New employees performing GMP work before training
- No periodic refresher training
- Training delivered by unqualified personnel
- Job-specific training gaps
- Training curriculum not updated after SOP revisions
Auditor Tips
Two training dimensions: (1) GMP fundamentals (applicable to all employees performing GMP work) and (2) job-specific training on SOPs, techniques, and equipment relevant to the individual's role. Initial training before independent work is essential. Ongoing training keeps personnel current with procedure updates and emerging practices. Training effectiveness should be assessed, not just attendance recorded.
Objective Evidence
- Individual employee training files
- Training matrix showing coverage by role
- Effectiveness assessment scores
- Competency observation records
- Retraining records triggered by events
- Training record retention per record retention policy
- Periodic training file audits
- Training database or LMS records
Common Nonconformities
- Training records incomplete or missing
- No effectiveness assessment recorded
- Competency not verified through observation
- Retraining not performed after SOP changes
- Training records destroyed before retention period
- Electronic training system lacking audit trail for completions
Auditor Tips
Training records are the regulatory evidence of employee competence. Each employee's file should contain dated training records with: course title, date, duration, trainer, and effectiveness assessment results. Periodic competency assessments (observations, tests, practical evaluations) verify retention. Retraining is triggered by procedure changes, performance issues, or scheduled cycles.
Objective Evidence
- Personnel hygiene SOP
- Illness reporting procedures
- Health screening at hire
- Exclusion procedures for ill personnel
- Wound/lesion reporting and handling
- Supervisor training on health observation
- Return-to-work clearance procedures
- Health and hygiene training records
Common Nonconformities
- Ill personnel working in production areas
- No procedure for reporting illness
- Open wounds not properly covered or excluded
- No supervisor training on health observation
- Return to work without medical clearance
- Hygiene monitoring absent during shift walkthroughs
Auditor Tips
Personnel hygiene prevents microbial contamination of products. Key controls: exclusion of ill personnel from production areas, proper hand washing, grooming (clean fingernails, no heavy cosmetics), no eating/drinking in production areas. Personnel with open wounds or infectious diseases should be restricted from production until cleared. This clause includes a positive responsibility for supervisors to observe and act on health issues.
Objective Evidence
- Gowning SOPs by area
- Gowning diagrams showing required attire
- Gowning training records
- Laundry procedures for reusable gowns
- Disposable gown stocks and use
- Area entry requirements posted
- Gowning observations during audits
- Gown change frequency requirements
Common Nonconformities
- Gowning requirements not enforced
- Same clothing worn between different areas
- Hair/beard covering not used
- Gowning inadequate for potent APIs
- No training on proper gowning technique
- Disposable garment stocks depleted without replenishment plan
Auditor Tips
Protective clothing has two purposes: protecting the product from personnel contamination and protecting personnel from the process. Clothing requirements vary by area: street clothes in offices, lab coats in general production, full gowning in cleanrooms or with potent APIs. Hair covering, beard covering, gloves, and eye protection may be required. Changing frequencies must be defined — daily typical, more frequent for high-risk areas.
Objective Evidence
- Contact avoidance procedures
- Glove use requirements and types
- Sampling techniques avoiding contact
- Closed system design documentation
- Manual operation risk assessments
- Training on contact avoidance
- Glove change frequency requirements
- Environmental controls during manual operations
Common Nonconformities
- Direct hand contact without gloves
- Inadequate glove types for the task
- Manual operations in uncontrolled environments
- No training on contact avoidance
- Gloves reused across different materials
- Engineering controls bypassed during manual charging operations
Auditor Tips
Direct skin contact with intermediates and APIs should be avoided through engineering controls (closed systems, automation) and protective equipment (gloves, sleeves, face shields). Where direct contact is unavoidable (e.g., sampling, manual charging), techniques must prevent contamination: sterile or cleaned gloves, clean sampling tools, limited exposure time, and environmental controls.
Objective Evidence
- Facility layout showing designated break areas
- Signage prohibiting food/drink in production
- Training on facility hygiene rules
- Break area separation verified
- Smoking cessation policy
- Compliance observations during audits
- Personal storage lockers outside production
- Enforcement procedures and consequences
Common Nonconformities
- Food/drink in production areas
- Personal medications in production
- Break areas adjacent to production without separation
- Smoking near production entrances
- Rules not consistently enforced
- Chewing gum or tobacco wrappers found in manufacturing zones
Auditor Tips
Dedicated break rooms/cafeterias separated from production prevent contamination. Common controls: physical separation with doorways/airlocks, signage at entry to production, enforcement during walkthroughs, training reinforcement. Smoking is prohibited in all production areas (often the entire facility). Personal medications are prohibited to prevent accidental contamination if containers spill.
Objective Evidence
- Health reporting procedure
- Anonymous reporting channels
- Supervisor training on health recognition
- Return-to-work medical clearance process
- Occupational health records
- Non-retaliation policy for reporting
- Periodic health screening program
- Health and safety committee records
Common Nonconformities
- No formal health reporting procedure
- Fear of reprisal preventing reports
- Return to work without clearance
- Supervisors untrained in health recognition
- No occupational health partnership
- Seasonal illness outbreaks without temporary staffing contingency
Auditor Tips
Proactive reporting of health issues prevents contamination. Personnel must feel comfortable reporting without fear of reprisal. Conditions to report: infectious diseases, gastrointestinal illness, respiratory infections, skin conditions, open wounds. Supervisors need training to recognize issues that employees may not self-report. A clear return-to-work procedure with medical clearance ensures safe return.
Objective Evidence
- Consultant qualifications files (CVs, certifications)
- Written consulting agreements
- Consultant engagement records
- QA review of consultant qualifications
- Scope of work documents
- Deliverable reviews and acceptance
- Confidentiality agreements
- Consultant performance feedback
Common Nonconformities
- Consultants used without documented qualifications
- No written agreements with consultants
- Consultant advice accepted without QA review
- Scope creep beyond qualified areas
- No record of consultant engagements
- Confidentiality agreements missing for external advisors
Auditor Tips
External consultants are commonly used for specialized areas: regulatory strategy, validation, specialized analytical methods, facility design. Like employees, consultants must be qualified for the advice they provide. Documentation of consultant qualifications (CVs, certifications, prior engagements) should be retained. Consulting services should be governed by written agreements defining scope, deliverables, and confidentiality.
Objective Evidence
- Consultant master file or database
- Individual engagement files
- Qualification documentation
- Service records and deliverables
- Retention per record retention policy
- Accessibility during audits
- Consultant list for QA review
- Annual consultant usage summary
Common Nonconformities
- Consultant records scattered or missing
- No centralized consultant information
- Deliverables not retained as records
- Consultants used without records
- Records not accessible during audits
- Retention period for consultant files shorter than GMP record requirements
Auditor Tips
Consultant records create the audit trail for external advice. Content: consultant name, company, contact information, qualifications, date(s) of engagement, scope of services, deliverables produced, compensation (optional but good practice). These records should be readily available during audits to demonstrate that any external advice came from qualified sources. Retention periods should match other GMP records.
Objective Evidence
- Facility design documents and drawings
- Site selection risk assessment
- Cleanability assessment during design
- Maintenance access evaluation
- Layout showing contamination prevention
- Environmental risk assessment for location
- Facility qualification records
- User requirements document for facility
Common Nonconformities
- Facility not designed for cleaning (inaccessible corners, rough surfaces)
- Cross-contamination risks from layout
- Inadequate separation of operations
- Facility location inappropriate for product type
- Design not reviewed by QA
- Facility modifications performed without updated qualification records
Auditor Tips
Facility design is foundational to GMP compliance. Design must support: cleaning (smooth surfaces, accessible corners), maintenance (adequate access, proper lighting), contamination prevention (appropriate layout, separation of operations), and operational efficiency. Location considerations include environmental factors (nearby industries, weather patterns) and logistical considerations (supplier access, utility availability). Microbial controls scale with API sensitivity.
Objective Evidence
- Facility layout showing separation
- Pressure cascade diagrams
- HVAC design with HEPA where required
- Material flow showing no backtracking
- Personnel flow plans
- Contamination control strategy
- Surface material specifications
- Microbial monitoring program
Common Nonconformities
- Material and personnel flows crossing contaminated areas
- Incompatible operations in shared spaces
- Inadequate air handling for product sensitivity
- Dirty and clean areas not separated
- Surfaces difficult to clean
- Microbial monitoring data showing persistent excursions in production zones
Auditor Tips
Contamination minimization through design includes: physical separation of incompatible operations (e.g., potent and non-potent materials), unidirectional flow to prevent backtracking, appropriate air handling with pressure cascades, cleanable surface materials, minimization of dust-generating areas. For microbially sensitive products, additional controls like HEPA filtration, positive pressure, and sanitization programs are needed.
Objective Evidence
- Facility layout showing all defined areas
- Access control systems for restricted areas
- Area designation signage
- Workflow documentation showing area usage
- Electronic segregation system validation (if used)
- Quarantine area documentation
- Lab operations area separation
- Material flow between areas
Common Nonconformities
- Activities occurring in inappropriate areas (e.g., sampling in warehouse aisles)
- No defined receiving area
- Laboratory operations in production areas
- Quarantine not physically or electronically separated
- Lab in proximity to sensitive operations
- Packaging and labelling operations sharing space with open processing
Auditor Tips
Each activity needs a defined area or control system. 'Defined areas' typically means physically separated rooms or zones. 'Other control systems' allows electronic segregation with effective access controls (e.g., a single warehouse with ERP-based status tracking). The list enumerates critical activities: receiving/quarantine, sampling, storage, production, packaging, laboratory. Missing any of these areas is a significant gap.
Objective Evidence
- Facility layout showing flow patterns
- Air flow diagrams matching flow patterns
- Pressure differential records
- Clean area specifications
- Disinfection procedures for clean areas
- Gowning rooms between areas
- Air lock design and use
- HVAC commissioning reports
Common Nonconformities
- Bi-directional flows creating contamination risks
- Personnel and material flows crossing
- Inadequate pressure differentials
- Clean areas without disinfection program
- No airlocks between different cleanliness grades
- Airflow verification studies not repeated after HVAC modifications
Auditor Tips
Open handling (e.g., charging powders, sampling, discharge) is a high-contamination-risk activity. Dedicated clean areas with appropriate controls minimize risk. Flow patterns should be unidirectional: materials move through the facility without crossing contaminated areas; personnel flow separates from material flow where possible; equipment moves through cleaning/sanitization as needed. Air handling supports flow by providing pressure differentials and cleanable airflow.
Objective Evidence
- Risk assessment for required separation
- Dedicated area documentation
- Campaign-based operation schedules
- Cleaning validation for shared equipment
- Separation philosophy document
- Product classification for separation requirements
- Regulatory filings reflecting separation
- Periodic review of separation adequacy
Common Nonconformities
- Highly potent and non-potent materials in shared facilities
- No dedicated areas for beta-lactams
- Biological materials sharing facilities with chemical APIs
- Separation philosophy not documented
- Risk assessment missing for shared operations
- Campaign-based cleaning validation insufficient for potent compound residues
Auditor Tips
Separation can be physical (dedicated rooms, equipment) or temporal (campaign-based operations on shared equipment). Physical separation is required for: highly potent materials (hormones, cytotoxics), beta-lactams, biological materials. Temporal separation with thorough cleaning validation may be acceptable for lower-risk products. Risk assessment determines the required level.
Objective Evidence
- Facility layout with space allocation
- Floor markings for material placement
- Storage area dimensions vs inventory
- Walkway and access width documentation
- Dedicated placement zones
- Material identification at placement
- Space review during facility changes
- Housekeeping standards
Common Nonconformities
- Overcrowded facilities with mix-up risks
- Materials placed wherever convenient
- Inadequate walkways obstructing movement
- No designated placement areas
- Pallet stacking creating identification difficulties
- Floor markings faded or absent in staging areas
Auditor Tips
Crowded facilities are error-prone. Adequate space allows for proper placement of materials with separation between different products/batches, unobstructed movement of personnel and equipment, and dedicated storage areas. Physical markings (floor tape, zones) help identify placement locations. Space planning during facility design considers maximum expected inventory and activity levels.
Objective Evidence
- Laboratory layout documentation
- Separation between QC labs and production
- IPC lab location justification
- Environmental controls for laboratories
- Cross-contamination assessment for in-production labs
- Laboratory equipment placement
- Vibration and environmental monitoring in labs
- Lab space adequacy review
Common Nonconformities
- QC laboratory adjacent to dusty operations
- Balance in high-vibration area
- Analytical HPLCs in solvent-laden atmosphere
- Lab operations disrupting production
- Inadequate lab space for workload
- Temperature excursions in analytical instrument rooms affecting measurement accuracy
Auditor Tips
Laboratory separation from production prevents cross-contamination and enables proper environmental control for sensitive analytical work. However, in-process control labs may be located close to production for efficiency. The key question: does the co-location compromise either the lab work or the production? Common problems: vibration affecting balances, dust contaminating samples, solvents interfering with HPLC, heat affecting analytical equipment.
Objective Evidence
- Utility qualification documents
- Monitoring plans by utility
- Utility monitoring records
- Excursion investigation records
- Current utility drawings
- Utility quality specifications
- Preventive maintenance for utilities
- Critical utility list with rationale
Common Nonconformities
- Utilities not qualified
- Monitoring not performed or infrequent
- Excursions not investigated
- Utility drawings outdated
- No distinction between critical and non-critical utilities
- Compressed air quality testing absent for product-contact applications
Auditor Tips
Utility impact on quality varies: process water directly contacts the product (highest impact), gases and compressed air contact product surfaces (medium impact), HVAC affects environmental quality (varies by area). Critical utilities require qualification (IQ/OQ/PQ) and ongoing monitoring. Monitoring frequency depends on criticality and stability. Out-of-limit excursions trigger investigation and product impact assessment.
Objective Evidence
- HVAC design documents
- Air change rate calculations
- HEPA filter specifications and test records
- Pressure differential monitoring
- Humidity and temperature monitoring
- HVAC qualification records
- Dust control measures
- Periodic HVAC performance review
Common Nonconformities
- Inadequate air changes for product type
- No HEPA filtration where required
- Pressure differentials not maintained
- HVAC recirculation from dusty areas
- No HVAC qualification
- HEPA filter integrity testing overdue or not scheduled
Auditor Tips
HVAC design affects both product quality and operator safety. Key elements: adequate air changes per hour (typically 10-20 for GMP areas), HEPA filtration for clean areas, pressure differentials to prevent cross-contamination, humidity control for moisture-sensitive processes, temperature control for operator comfort and process needs. Once-through air (no recirculation) is common for dusty or sensitizing materials.
Objective Evidence
- Pipe identification scheme documentation
- Color coding standards
- Piping labels observed in facility
- P&IDs matching field identification
- Maintenance procedures requiring pipe identification
- Periodic audit of pipe identification
- New installation procedures requiring identification
- Training on pipe identification
Common Nonconformities
- Piping not labeled
- Inconsistent color coding across facility
- P&IDs not matching field reality
- Maintenance errors from mis-identified pipes
- Piping routed through sensitive areas
- Flow direction arrows missing on critical utility piping
Auditor Tips
Pipe identification prevents cross-connection errors during maintenance or modifications. Common approaches: color coding, flow direction arrows, content labels at intervals along the pipe, tags at connections. The identification scheme should be documented and consistent across the facility. P&IDs provide the documented system for identifying piping within control systems.
Objective Evidence
- Drain design documentation
- Air break verification
- Drain trap maintenance records
- Pest control records
- Drain cleaning procedures
- Periodic drain inspection
- Drain locations on facility drawings
- Back-flow prevention devices
Common Nonconformities
- Drains without air breaks where required
- Back-flow devices not present or not maintained
- Dried drain traps allowing sewer gas ingress
- No pest control around drains
- Drains inadequate for waste volume
- Drain cleaning not included in facility sanitation programme
Auditor Tips
Floor drains can be contamination sources if not properly designed. Air breaks prevent back-siphonage from sewer lines into processing areas. Traps prevent sewer gas entry. Covers prevent pest ingress. Drain locations should facilitate cleaning (liquid waste draining to collection) without creating contamination paths to clean areas. Drain trap water should be regularly flushed to maintain water seal.
Objective Evidence
- Heating/cooling system specifications
- Media quality specifications
- Jacket leak detection procedures
- System capacity calculations
- Thermal mapping studies
- Heat transfer fluid selection rationale
- Direct contact system qualification
- Periodic system performance review
Common Nonconformities
- Inadequate heating/cooling capacity
- Heat transfer fluids not compatible with process
- No leak detection for jackets
- Steam quality inadequate for direct contact
- Systems not qualified
- Thermal mapping studies not conducted for critical process vessels
Auditor Tips
Heating/cooling systems include steam, hot water, chilled water, glycol cooling, cryogenic cooling. Direct contact (e.g., steam injection, cooling via direct contact) requires higher quality media. Indirect contact (jacket heating/cooling) has lower risk but still requires leak prevention and appropriate media selection. Heat transfer fluids should be compatible with the process and selected based on temperature ranges.
Objective Evidence
- Water quality specifications document
- Water system qualification reports
- Water testing records
- Justification for water quality grade
- WHO drinking water compliance for process water
- Water system monitoring data
- Endotoxin testing (where applicable)
- Water use point specifications
Common Nonconformities
- Process water below WHO drinking water quality
- No water quality specifications
- Water testing infrequent or missing
- Quality grade not justified for API sensitivity
- No endotoxin testing for injectable API water
- Water system alert and action limits not defined
Auditor Tips
Water quality must be appropriate for the API. WHO drinking water is the absolute minimum for process contact. Higher grades (Purified Water, Water for Injection) are required for more sensitive APIs. The water quality specifications must cover: chemical attributes (pH, conductivity, TOC), microbial limits (total count, specific organisms), and for injectable APIs, endotoxin limits. Specifications should be justified by the intended use.
Objective Evidence
- API intended use documentation
- Water treatment process flow diagram
- Water system qualification with intended use justification
- Purified Water or WFI qualification
- Endotoxin monitoring for injectable-grade water
- Distillation or RO validation
- Microbial control program
- Point-of-use sampling and testing
Common Nonconformities
- APIs for injectable products using drinking water in final steps
- Endotoxin not monitored for sterile API precursor water
- Water system not qualified for intended grade
- No distinction between water grades by process step
- Final purification water quality not justified
- Reverse osmosis membrane integrity testing not scheduled
Auditor Tips
APIs for injectable products need enhanced water quality in final steps. Typically: Purified Water (USP) or Water for Injection (WFI) depending on proximity to the sterile drug product. WFI is the highest quality with strict endotoxin limits (< 0.25 EU/mL). The treatment train typically includes: pretreatment, reverse osmosis, deionization, distillation (for WFI), storage with recirculation, and point-of-use filtration.
Objective Evidence
- Water system specifications
- Sampling plan with points and frequency
- Daily water testing records
- Continuous monitoring data (conductivity, TOC)
- Trending reports
- Excursion investigation records
- Sampling point rationale
- Test method validation
Common Nonconformities
- Water specs not defined or not monitored
- Sampling frequency inadequate
- Trending not performed
- Excursions not investigated
- Sampling points not representative
- Dead-leg segments in distribution loop not included in sampling plan
Auditor Tips
A complete water program requires: written specifications, a qualified water system capable of meeting specs, sampling plan with frequency based on risk, validated test methods, trending of results, investigation of excursions. Sampling points should represent worst-case locations (furthest from treatment, dead legs if any, use points). Testing frequency is typically daily for microbiological and continuous for conductivity/TOC.
Objective Evidence
- Water system maintenance schedule
- Sanitization procedures and frequency
- Sanitization validation records
- Preventive maintenance records
- Filter change records
- Biofilm prevention measures
- System performance during sanitization
- Post-sanitization microbial verification
Common Nonconformities
- Water system not sanitized regularly
- Sanitization not validated
- Biofilm visible or suspected
- Maintenance not performed on schedule
- Filters not replaced per schedule
- Post-sanitization microbial recovery counts not trended over time
Auditor Tips
Water systems are living systems that require ongoing care. Microbial biofilm growth is the primary risk. Controls include: recirculating loops (maintaining velocity), hot water storage (inhibits growth), periodic sanitization (heat or chemical), filter replacements, and UV treatment where used. Sanitization validation demonstrates that the procedure actually reduces microbial burden. Maintenance activities are documented to show compliance with schedules.
Objective Evidence
- Water treatment process validation
- Treatment effectiveness data
- Action limit definitions
- Water quality matching process needs
- Chemical contaminant removal validation
- Treatment monitoring records
- Non-sterile API water specifications
- Water use point controls
Common Nonconformities
- Treatment process not validated
- Action limits not defined
- Treatment inadequate for process chemistry
- No monitoring of treatment effectiveness
- Chlorine/chloramine affecting reactions without removal
- Conductivity or TOC trending showing gradual treatment degradation
Auditor Tips
Most APIs are non-sterile (intended for oral, topical, or other non-injectable dosage forms) and don't require WFI. However, water treatment is often still used to remove specific contaminants (e.g., chlorine that could affect reactions, hardness causing scale, iron affecting catalysts). The treatment process and final water quality must be validated for the intended use. Action limits trigger investigation before specs are breached.
Objective Evidence
- Dedicated facility documentation for sensitizing products
- Separate air handling for beta-lactams
- Risk assessment for product dedication decisions
- Cleaning validation for shared facilities (where allowed)
- Inactivation procedures validated
- Regulatory submissions reflecting dedication
- Facility certification for product types
- Management approval of dedication decisions
Common Nonconformities
- Beta-lactams in shared facilities without dedication
- Cytotoxics sharing air handling with other products
- No dedicated areas for highly sensitizing materials
- Cleaning validation not adequate for product type
- Regulatory expectations not met
- Cross-contamination risk assessment not updated after product portfolio changes
Auditor Tips
Beta-lactam antibiotics (penicillins, cephalosporins) can cause severe allergic reactions even at trace levels — so they require dedicated facilities with their own air handling. Cytotoxic APIs, hormones, and highly potent compounds typically also require dedicated facilities unless exceptionally rigorous cleaning can be validated. This is one of the most important clauses in ICH Q7 and triggers significant facility investment for some products.
Objective Evidence
- BSL classification for each biological material
- Facility design matching BSL requirements
- Containment equipment qualification
- HEPA exhaust for containment
- Access controls to containment areas
- Operator protection procedures
- Biological waste handling
- BSL training records
Common Nonconformities
- BSL facilities inadequate for biological type
- No HEPA exhaust in containment
- Access controls missing
- Operator protection inadequate
- Biological waste handled without containment
- Decontamination procedure validation records absent for biosafety equipment
Auditor Tips
Biological materials require BSL (biosafety level) appropriate facilities: BSL-1 for non-pathogenic, BSL-2 for moderate-risk, BSL-3 for serious, BSL-4 for lethal. Each level has specific design requirements including containment, air handling (HEPA exhaust), access controls, and operator protection. Classical fermentation products typically use BSL-1, while pathogenic organisms (rare in API manufacturing) require higher levels.
Objective Evidence
- Containment strategy document
- Potency classification (OEB/OEL)
- Engineering controls for each potent API
- Containment equipment qualification
- Industrial hygiene monitoring
- PPE requirements by product
- Training on containment procedures
- Worker exposure monitoring
Common Nonconformities
- Potency not classified
- Engineering controls inadequate for potency
- Reliance on PPE for highly potent materials
- No industrial hygiene monitoring
- Containment not validated
- Occupational exposure limit not established for new potent compounds
Auditor Tips
Potent APIs (occupational exposure limit < 10 μg/m³) require enhanced containment. The containment strategy uses the hierarchy of controls: engineering (best), administrative (procedures), PPE (last line). Engineering controls include: isolators for highest potency, downflow booths for moderate, local exhaust for lower. Procedural controls: gowning, limited access, campaign production. PPE: respiratory protection, chemical suits.
Objective Evidence
- Cytotoxic product list
- Dedicated facility or rigorous cleaning validation
- OEL-based cleaning limits
- Cleaning validation with analytical sensitivity
- Environmental monitoring for cytotoxics
- Worker exposure assessment
- Disposal of cytotoxic waste
- Patient safety justification for shared facilities
Common Nonconformities
- Cytotoxics in shared facilities without adequate validation
- Cleaning limits not OEL-based
- No environmental monitoring
- Worker exposure not assessed
- Risk assessment favoring convenience over safety
- Analytical methods lacking sensitivity to detect residues at health-based limits
Auditor Tips
Cytotoxic APIs (anti-cancer drugs) present dual risks: patient harm from cross-contamination and occupational health harm to workers. Dedicated facilities are strongly preferred. Where shared facilities are used (sometimes necessary for commercial reasons), validation must be rigorous: OEL-based cleaning limits (often in the ng/cm² range), orthogonal analytical methods, worst-case product validation, environmental monitoring, worker exposure verification.
Objective Evidence
- Lighting level specifications by area
- Lighting surveys or measurements
- Fixture specifications (sealed for product areas)
- Emergency lighting testing records
- Task-appropriate lighting validation
- Lighting maintenance schedule
- Energy-efficient lighting (LED conversions)
- Periodic lighting level verification
Common Nonconformities
- Lighting inadequate for visual inspection tasks
- Open fixtures in product areas
- No emergency lighting
- Shadowed areas impeding operations
- Lighting not appropriate for task
- Lighting level surveys not performed or documented
Auditor Tips
Lighting adequacy varies by task: visual inspection requires high illumination (500+ lux), general work areas moderate (300 lux), storage lower (150 lux). Lighting fixtures in production areas should be sealed to prevent insect accumulation and dust infiltration. Emergency lighting for safe egress is required by building codes. Dim or shadowed areas create contamination and safety risks.
Objective Evidence
- Waste management SOP
- Waste container labeling
- Waste segregation records
- Hazardous waste manifests
- Contractor qualifications for waste disposal
- Waste water treatment records
- Regulatory permits for waste
- Waste handling training
Common Nonconformities
- Waste accumulating in production areas
- Containers not labeled
- Hazardous waste mixed with general waste
- Contractors not qualified
- No waste management SOP
- Hazardous waste manifests incomplete or missing disposal certificates
Auditor Tips
Waste management prevents contamination and environmental harm. Key controls: segregated waste streams (general, hazardous, biological, cytotoxic), clearly labeled containers, timely removal to prevent accumulation, proper disposal per regulations (RCRA, EPA, etc.). Waste water treatment or disposal per permits. Contractors handling hazardous waste must be qualified and documented.
Objective Evidence
- Building maintenance SOP
- Preventive maintenance schedule for facilities
- Maintenance work order records
- Contractor GMP training
- Maintenance activities during production controls
- Facility condition assessments
- Maintenance CAPA for recurring issues
- Annual facility inspection
Common Nonconformities
- Facility condition deterioration visible
- Maintenance performed without contamination controls
- Contractors without GMP awareness
- No preventive maintenance schedule
- Reactive maintenance only
- Peeling paint or cracked epoxy flooring in production areas
Auditor Tips
Building maintenance keeps facilities suitable for GMP use. Common issues include: paint peeling, wall cracks, ceiling damage, floor wear, window failures, HVAC degradation. Maintenance must be planned and performed without creating contamination or disrupting operations. Contractors performing maintenance need GMP awareness training. Maintenance during production requires contamination controls (partitions, vacuum systems).
Objective Evidence
- Sanitation SOPs with responsibilities
- Cleaning schedules posted
- Waste disposal SOPs
- Spill response procedures
- Cleaning material approved list
- Cleaning verification procedures
- Emergency response procedures
- Waste disposal training
Common Nonconformities
- Sanitation procedures missing or inadequate
- Responsibilities unclear
- Spill procedures not tested or known
- Waste disposal without formal SOPs
- Emergency response not practiced
- Cleaning agent residue not verified after facility sanitation
Auditor Tips
Sanitation procedures integrate with waste disposal to maintain clean facilities. Written procedures define: who is responsible, what is cleaned, how frequently, what cleaning materials/tools, what verification. Waste procedures cover: routine waste streams, spill response, accident cleanup. Emergency procedures for large spills or unusual events prevent escalation.
Objective Evidence
- Cleaning schedule documents
- Cleaning completion records
- Visual verification records
- Analytical verification where applicable
- Environmental monitoring trending
- Cleaning effectiveness metrics
- Cleaning training records
- Cleaning SOP training verification
Common Nonconformities
- Cleaning performed but not recorded
- Schedules not followed
- No verification of cleaning effectiveness
- Environmental monitoring not linked to cleaning
- Recurring environmental issues without cleaning program review
- Cleaning agent dilutions prepared without documented concentration verification
Auditor Tips
Cleaning records document compliance with schedules. Content: date, time, area cleaned, cleaning agent used, operator signature. Verification ranges from visual inspection (minimum) to analytical testing (for critical surfaces). Environmental monitoring data correlates cleaning effectiveness with microbial control. Trending reveals cleaning program weaknesses.
Get the Full 350-Item Checklist
Download the complete ICH Q7 audit checklist with all 350 expert items, objective evidence requirements, common nonconformities, auditor tips, and a professional scoring rubric.
This checklist is an educational resource for audit preparation. It does not constitute professional regulatory advice. Always consult qualified auditors for certification decisions.